<DOC>
	<DOCNO>NCT01692236</DOCNO>
	<brief_summary>Background : - Human immunodeficiency virus ( HIV ) infection appear cause problem blood vessel function . These problem may add think mood disorder find people HIV infection . Researchers want evaluate HIV infect patient see blood vessel function contribute think mood disorder , early dementia depression . To , compare study result people people without HIV infection . Objectives : - To compare thickness blood vessel wall people without HIV infection . - To study relationship blood vessel thickness think mood disorder . Eligibility : - Individuals 25 55 year age HIV infection . - Healthy individual 25 55 year age . Design : - Participants screen physical exam medical history . Blood urine sample collect . - Participants image study brain major blood vessel head neck . - Participants also neuropsychological test . These test look memory , learn think ability , attention , mood . - Participants option come back repeat blood test every six month repeat image study neuropsychological test every year , 1- 4 year period .</brief_summary>
	<brief_title>Brain Imaging HIV-Associated Thinking Mood Disorders</brief_title>
	<detailed_description>With combination antiretroviral therapy , HIV/AIDS transform progressive , usually fatal infection manageable chronic condition . Yet , HIV associate neurocognitive disorder ( HAND ) pose significant clinical problem , even among patient control HIV viremia . There evidence accelerate vascular age vascular disorder HIV-infected ( HIV+ ) people , study suggest association vascular disorder unfavorable neurocognitive outcome . Thus , one possible contribute factor high rate HANDs depression could vascular dysfunction , similar vascular depression vascular dementia occur elderly non-HIV+ individual . One commonly use diagnostic marker vasculopathy thicken vessel wall . Multiple study already establish correlation vessel wall thicken vascular disease manifestation . This prospective observational study aim examine relationship neurocognitive depression outcome vessel wall thickness marker vascular disease HIV+ adult . We use neuropsychological testing , brain imaging , blood biomarkers , state-of-the-art high-resolution MR image carotid vessel wall . HIV infect patient ( n=40 ) HIV-negative control ( n=40 ) recruit . Participants consent longitudinal follow-up follow two year clinical evaluation every 6 month repeat image study 12 24 month . Cross sectional data analysis compare marker vascular neurocognitive disorder HIV-infected HIV-negative participant . The longitudinal data analysis ass compare temporal progression vascular disease ( image blood biomarker finding ) relation change neurocognitive depression score group .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Neurocognitive Disorders</mesh_term>
	<criteria>INCLUSION CRITERIA : Inclusion criterion participant : 1 . Age 2561 year . 2 . Willingness allow store sample , human leukocyte antigen ( HLA ) testing , future genetic testing . 3 . Hemoglobin le equal 9.0 g/dL , HCT le equal 28 % , platelets less equal 50,000/microL . 4 . English language fluency ( required neuropsychological testing ) . Additional inclusion criterion HIV+ participant : 1 . Documented HIV infection standard HIV testing . Prior documentation HIV antibody status NIH accept lieu repeat test . 2 . HIV viral load limit detection combination antiretroviral therapy less equal 1 year . 3 . Under care primary care physician . Additional inclusion criterion HIVnegative participant : 1 . HIVantibody negative . EXCLUSION CRITERIA : Exclusion criterion participant : 1 . Contraindication MRI scanning , include pacemaker implant electrical device , brain stimulators , type dental implant , aneurysm clip ( metal clip wall large artery ) , metallic prosthesis ( include metal pin rod , heart valve , cochlear implant ) , permanent eyeliner , implanted delivery pump , shrapnel fragment . 2 . Subjects condition preclude entry scanner acquisition scan ( e.g. , morbid obesity , claustrophobia , back pain , motion disorder ) . 3 . Glomerular filtration rate &lt; 45 mL/min/1.73 ( 2 ) estimate use Modified Diet Renal Disease equation . 4 . Allergy qadolinium ( MRI contrast ) 5 . Evidence current prior central nervous system opportunistic infection ( ) and/or spaceoccupying lesion primary CNS lymphoma . 6 . Prior history intrathecal chemotherapy radiation therapy brain . 7 . History current diagnosis systemic vasculitis . 8 . Active systemic infection malignancy require therapy . 9 . Psychiatric condition interfere ability participate study procedure provide inform consent . 10 . Patient provider report alcohol drug abuse ongoing within 3 month prior participation . 11 . Sickle cell disease ( due know association vasculopathy ) . 12 . Systolic blood pressure less equal 180 mmHg screening . 13 . Persons infect hepatitis C virus ( HCV ) treat plan seek treatment HCV . 14 . Women lactate , pregnant , actively seek become pregnant . 15 . Other known clinical condition condition discover MRI , discretion investigator , precludes serial clinical , neuropsychological , imaging evaluation . Additional exclusion criterion HIV+ participant 1 . HIV acquire perinatally ( due potential effect HIV antiretroviral therapy neurocognitive vascular development ) .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>61 Years</maximum_age>
	<verification_date>May 3, 2016</verification_date>
	<keyword>MRI</keyword>
	<keyword>HIV</keyword>
	<keyword>Neurocognitive Disorders</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Vasculopathy</keyword>
</DOC>